Document:

implantable_8k-ex1004.htm

    Exhibit 10.4

     

    

    ASSIGNMENT OF
PATENT

    

    THIS ASSIGNMENT OF PATENT (the “Assignment”) is made,
executed and delivered as of this 28th day of
July, 2008, by and among Implantable Vision, Inc., a Utah corporation (“Assignor”), and BT
Acquisitions, Inc., a Colorado corporation (“Assignee”).

    

    W I T N E S S E T H

    

    WHEREAS, Assignor is the sole
owner of the entire right, title and interest in and to the inventions,
applications for Letters Patent, and Letters Patent listed on Exhibit A attached
hereto in all countries throughout the world; and

    

    WHEREAS, Assignee is desirous
of securing Assignor’s entire right, title and interest in and to the
inventions, applications for Letters Patent and Letters Patent listed on Exhibit A attached
hereto, as well as any applications for Letters Patent that may lawfully be
filed for such inventions in all countries throughout the world, and any Letters
Patent issuing from such applications.

    

    NOW, THEREFORE, be it known
that for good and valuable consideration, hereby acknowledged to have been
received by Assignor, the parties hereby agree that Assignor has sold, assigned,
transferred, and set over, and does hereby sell, assign, transfer, and set over
unto Assignee, its lawful successors and assigns, Assignor’s entire right,
title, and interest in and to the inventions listed on Exhibit A, together
with any patent application which has been or may hereafter be filed thereon,
and/or issued patent and all divisions, continuations, continuations-in-part,
substitutes and renewals thereof, and all Letters Patent of the United States
which may be granted thereon, and all extensions, renewals, reissues and
re-examinations thereof, and all choses in action which may be based thereon,
and all rights to claim and contest priority on the basis of any such
application, and all applications for Letters Patent which have been or may
hereafter be filed for these inventions in any foreign country and all Letters
Patent which have been or may hereafter be granted on these inventions in any
foreign country, and all extensions, renewals, reissues and re-examinations
thereof; and Assignor hereby authorizes and requests the Commissioner of Patents
of the United States and any official of any foreign country whose duty it is to
issue patents on applications as described above, to issue all Letters Patent
for these inventions to Assignee, its successors and assigns, and/or to assign
already issued Letters Patent to Assignee in accordance with the terms of this
Assignment;

    

    AND, Assignor HEREBY covenants
that Assignor has the full right to convey the interest assigned by this
Assignment, has not conveyed any interest or right in or to the inventions,
applications for Letters Patent and Letters Patent to any third party, and
Assignor has not executed and will not execute any Agreement in conflict with
this Assignment;

    

    

    
      
        
           

        

        
          1

          
            

          

        

        
           

        

      

    

    

    AND, Assignor HEREBY further
covenants and agrees that Assignor will, without further consideration,
communicate with Assignee, its successors and assigns, any facts known to
Assignor respecting these inventions, and testify in any legal proceeding, sign
all lawful papers when called upon to do so, execute and deliver any and all
papers that may be necessary or desirable to perfect the title to these
inventions, applications for Letters Patent and Letters Patent in said Assignee,
its successors and assigns, execute all divisional, continuation, and reissue
applications, make all rightful oaths and generally do everything possible to
aid Assignee, its successors, and assigns, to obtain and enforce proper patent
protection for these inventions, applications for Letters Patent and Letters
Patent in the United States and any foreign country, it being understood that
any expense incident to the execution of such papers shall be borne by Assignee,
its successors and assigns.

    

    [remainder
of page intentionally left blank; signature page follows]

     

     

     

     

     

     

     

     

     

     

     

    

    
      
        
           

        

        
          2

          
            

          

        

        
           

        

      

    

    

    

    IN TESTIMONY WHEREOF, an
authorized representative of Assignor and Assignee have each hereunto set their
hands this 28th day of
July, 2008.

    

    

    
      	 
      	
              IMPLANTABLE
      VISION, INC.

            
	 
      	 
      
	 
      	 
      
	 
      	
              By:
      /s/ Bryan
      Bulloch                           
      

            
	 
      	
              Name:
      Bryan Bulloch

            
	 
      	
              Title:
      President and Chief Financial Officer

            
	 
      	 
      
	 
      	 
      
	 
      	
              BT
      ACQUISITIONS, INC.

            
	 
      	 
      
	 
      	 
      
	 
      	 
      
	 
      	
              By: /s/ George
      Rozakis                           
      

            
	 
      	
              Name:    George
      Rozakis

            
	 
      	
              Title:    President

            

    

    

     

     

     

     

     

     

     

     

     

     

    
 

    
      
        
           

        

        
          3

          
            

          

        

        
           

        

      

    

    

    

    ACKNOWLEDGEMENT
BY NOTARY PUBLIC:

    

    STATE OF
TEXAS       
                     )

    )           ss.:

    COUNTY
OF                                         )

    

    On the 29th day of July, in the year
2008 before me, the undersigned, personally appeared Bryan Duvall Bulloch,
personally known to me or proved to me on the basis of satisfactory evidence to
be the individual (s) whose name(s) is (are) subscribed to the within instrument
and acknowledged to me that he/she/they executed the same in his/her/their
capacity(ies), and that by his/her/their signature(s) on the instrument, the
individual(s), or the person(s) upon behalf of which the individual(s) acted,
executed the instrument.

    

    

     

    
       

      
        	 	
                /s/
      T. Sharp            

                Notary
      Public

                My
      Commission Expires:

              

      

       

    

     

    SEAL

    T. Sharp

    Notary
Public

    State of
Texas

    Comm Exp.
10-05-2011

    

    

    
      STATE OF
NEW
YORK                     )

      )           ss.:

      COUNTY
OF                                         )

    On the 29 day of July, in the year 2008
before me, the undersigned, personally appeared George W. Rozakis, personally
known to me or proved to me on the basis of satisfactory evidence to be the
individual (s) whose name(s) is (are) subscribed to the within instrument and
acknowledged to me that he/she/they executed the same in his/her/their
capacity(ies), and that by his/her/their signature(s) on the instrument, the
individual(s), or the person(s) upon behalf of which the individual(s) acted,
executed the instrument.

    

     

     

    
      	 	
              /s/
      Sandy A. Tollett        

              Notary
      Public

              My
      Commission Expires:

            

    

    

    SEAL

    Sandy A.
Tollett, Notary

    State of
Ohio

    My Commission
Expires: 3/30/10

    

    

    
      
        
           

        

        
          4

          
            

          

        

        
           

        

      

    

    

    
      EXHIBIT
A

      

      List of
Inventions

      

      INVENTIONS

      

      Title                                           Inventor(s)

      

      

      PATENT
APPLICATIONS

      

      
        	
                Title

              	
                Filing
      Date

              	
                Japanese Application
      No.

              
	 
      	 
      	 
      
	 
      	 
      	
                2001-51980

              
	 
      	 
      	
                10-519657

              
	 
      	 
      	
                2002-508351

              
	 
      	 
      	
                2001-548033

              
	 
      	 
      	 
      
	 
      	 
      	
                United States
      Application No.

              
	
                Posterior
      Chamber Phakic Intraocular Lens

              	
                11/12/2006

              	
                10/988,157

              
	
                Posterior
      Chamber Phakic Intraocular Lens

              	
                12/11/2006

              	
                11/637,475

              
	
                Multifocal
      Phakic Intraocular Lens

              	
                7/27/2007

              	
                11/829615

              
	
                Posterior
      Chamber Phakic Intraocular Lens

              	
                9/19/2007

              	
                11/857,476

              
	
                Posterior
      Chamber Phakic Intraocular Lens

              	
                10/19/2007

              	
                11/875,402

              

      

      

      

      PATENTS

      

      
        	
                Title

              	
                Issue
      Date

              	
                Serial
      No.

              
	 
      	 
      	 
      
	
                Floating
      phakic refractive lens design for preserving eye dynamics

              	 
      	
                US
      6706066

              
	
                Self-centering
      phakic intraocular lens

              	 
      	
                US
      6015435

              
	
                Self-centering
      phakic intraocular lens

              	 
      	
                US
      6428574

              
	
                Anatomically
      compatible posterior chamber phakic refractive lenses

              	 
      	
                US
      6506212

              
	
                Methods
      of surface treatment for enhancing the performance of a floating phakic
      refractive lens design

              	 
      	
                US
      6638307

              
	 
      	 
      	 
      

      

      

    

     

     

    5americanecology_ex1065.htm

    
      

      EXHIBIT
10.65

      

      AMERICAN
ECOLOGY CORPORATION

      

      FORM
OF INCENTIVE STOCK OPTION AGREEMENT

             

      Effective __________________, 2008 (the
“Effective Date”), American Ecology Corporation, a Delaware corporation (the
“Company”) hereby grants to * (the “Optionee”), an Incentive Stock Option to
purchase from the Company, at a price of * per share, * shares of the Company’s
authorized and unissued common stock, $0.01 par value per share (the “Common
Stock”) subject, however, to the following terms and conditions.

      

      1.           Incentive Stock
Option. This stock option is
designated as an Incentive Stock Option under Section 422 of the Internal
Revenue Code of 1986, as amended (the “Code”).  If, during one taxable
year, this stock option and any other Incentive Stock Options granted to you by
the Company or its subsidiaries vests for Common Stock with an aggregate fair
market value in excess of $100,000, then the stock option, as to the excess,
shall be treated as a non-statutory stock option that does not meet the
requirements of Section 422 of the Code.  If and to the extent that
the stock option fails to qualify as an Incentive Stock Option under the Code,
the stock option shall remain outstanding according to its terms as a
non-statutory stock option.

       

      2.           Stock Option
Plan.  This Stock Option Agreement (the “Agreement”) and the stock
option granted herein are made and accepted pursuant to and in accordance with
the Company’s 2008 Stock Option Incentive Plan (the “Plan”).  The
terms and provisions of the Plan, and any amendments thereto, are incorporated
herein by reference.  Unless specifically set forth herein, in the
event of any conflict between the provisions of this Agreement and the
provisions of the Plan, the provisions of the Plan will
prevail.  Unless otherwise stated, all capitalized terms used herein
shall have the meanings set forth in the Plan.

      

      3.          Term and
Vesting.  The stock option granted herein shall vest and become
exercisable as follows, provided the Optionee remains employed by the Company or
its subsidiaries through each applicable vesting date:

      

      
        	
                ●

              	
                34%
      of the stock option shall vest on the first anniversary of the Effective
      Date;

              

      

      
        	●	
                33%
      of the stock option shall vest on the second anniversary of the Effective
      Date; and

              

      

      
        	
                ●

              	
                The
      final 33% of the stock option shall vest on the third anniversary of the
      Effective Date.

              

      

      

      Subject
to the terms of the Plan and your continued employment with the Company or any
of its subsidiaries, your stock option will remain exercisable until the tenth
anniversary of the Effective Date (the “Expiration
Date”).  Upon the date of termination of your employment with
the Company and its subsidiaries (a “Termination Date”),
your stock option shall remain exercisable (the “Exercise Period”)
only in accordance with the following provisions:

      

      (a)           Upon
the termination of your employment with the Company or any of its subsidiaries
other than as a result of your death or total disability, any vested portion of
your stock option shall remain exercisable until the earlier of (i) thirty (30)
days after your Termination Date or (ii) the Expiration Date.

      

      (b)           Upon
the termination of your employment with the Company and its
subsidiaries by reason of your death or total disability, any vested portion of
your stock option shall remain exercisable until the earlier of: (i) twelve (12)
months after your Termination Date or (ii) the Expiration Date.

      

      Any
vested and exercisable portion of your stock option that is not so exercised
within the applicable Exercise Period shall be forfeited with no further
compensation due to you.  Additionally, unless otherwise provided by
the Compensation Committee, any portion of your stock option that is not vested
or exercisable as of your Termination Date shall be immediately forfeited on
such date with no further compensation due to you.

      

      4.
            Limitation Upon
Transfer.  The stock option granted herein (a) shall be
nonassignable and nontransferable by the Optionee, either voluntarily or by
operation of law, except by will or by the laws of descent and distribution of
the state or country of the Optionee’s domicile at the time of death, (b) during
the Optionee’s lifetime, shall be exercisable only by the Optionee, and (c)
shall, under no circumstances, be transferable in exchange for
consideration.

       

       

      
        
          
          

        

        
          24

          
            

          

        

        
          
          

        

         

      

      5.            Method of
Exercise.  The stock option granted herein may be exercised in whole
or in part by tendering to the Company written notice of exercise accompanied by
the aggregate purchase price for the shares with respect to which this stock
option is being exercised.  The purchase price of shares of Common Stock of
the Company acquired upon the exercise of this stock option shall be paid by the
Optionee by the delivery of cash or check payable to the order of the Company,
or with the consent of the Board of Directors, in whole or in part, Common Stock
of the Company valued at fair market value. With the consent of the Board of
Directors, the Optionee may request the Company to apply automatically the
shares to be received upon the exercise of a portion of the stock option (even
though stock certificates have not yet been issued) to satisfy the purchase
price for additional portions of the stock option subject to future
exercise.

      

      6.           Disqualifying
Disposition.  If your dispose of any shares of Common Stock
acquired upon the exercise of this stock option within two years from the
Effective Date or one year after such shares were acquired pursuant to the
exercise of this stock option (either disposition, a “Disqualifying
Disposition”), you acknowledge and agree that you shall notify the
Company in writing of such disposition.  Any notice of a Disqualifying
Disposition must be given within 30 days of such disposition.

      

      7.           Registration of
Stock.  Notwithstanding any of the provisions of this
Agreement, the stock option granted herein will not be exercisable, in whole or
in part, unless (a) all shares issuable on the exercise thereof have been
registered under the Securities Act of 1933, as amended (the “1933 Act”), or (b)
the Company shall have received an opinion of its counsel that registration
under the 1933 Act and all other applicable securities laws is not required in
connection with such issuance.  The Optionee further agrees that all
shares acquired under the exercise of the stock option granted hereunder will
not be sold or transferred unless such shares have been registered for resale
under the 1933 Act or unless the Company shall receive an opinion of counsel
satisfactory to it that such shares may be resold without registration under the
1933 Act.

      

      8.            Successors of
Company and Optionee.  This Agreement shall inure to the benefit of
and be binding upon the Company and the Optionee and their respective heirs,
legal representatives, successors and assigns, subject to the restrictions on
assignability and transferability set forth herein.

      

      9.           Adjustments.  The
number of shares of Common Stock and prices per share contained herein shall be
proportionately adjusted from time to time as and when provided in the
Plan.

      

      10.           Taxes.  Optionee
shall be responsible to make appropriate provisions for all taxes required to be
paid in connection with the stock option granted herein and the exercise
thereof.

      

      [Signature Page
Follows]

      

      
        
          
             

          

          
            25

            
              

            

          

          
             

          

        

      

      

      

      IN WITNESS WHEREOF, this Agreement has
been executed this * day of *, 2008.

       

      
        
          	 	 	
                   AMERICAN
      ECOLOGY CORPORATION

                   

                   

                	 
	 	By:	Jeffery R.
      Feeler	 
	 	Its:	Vice President &
      Chief Financial Officer	 
	 	 	 	 	 
	 	 	
                  OPTIONEE

                   

                   

                	 
	 	 	 Name:
      

                  Address:

                  SS#:

                	
                  *

                  *

                  *

                	 

        

         

      

       

       
26

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]